524414
NORRIS
Start SIP
Invest Now
Start SIP in NORRIS
Performance
- Low
- ₹15
- High
- ₹15
- 52 Week Low
- ₹13
- 52 Week High
- ₹23
- Open Price₹15
- Previous Close₹15
- Volume1,634
- 50 DMA₹14.94
- 100 DMA₹15.57
- 200 DMA₹16.31
Investment Returns
- Over 1 Month -13.33%
- Over 3 Month -12.65%
- Over 6 Month -14.56%
- Over 1 Year -35.98%
Smart Investing Starts Here Start SIP with Norris Medicines for Steady Growth!
Norris Medicines Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -9.4
- PEG Ratio
- 0.1
- Market Cap Cr
- 15
- P/B Ratio
- -0.9
- Average True Range
- 1.07
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.55
- RSI
- 50.34
- MFI
- 70.14
Norris Medicines Financials
Norris Medicines Technicals
EMA & SMA
Current Price
₹14.50
0
(0%)
- Bearish Moving Average 8
- Bullish Moving Average 8
- 20 Day
- ₹14.23
- 50 Day
- ₹14.94
- 100 Day
- ₹15.57
- 200 Day
- ₹16.31
Resistance and Support
14.78
- R3 15.92
- R2 15.63
- R1 15.07
- S1 14.22
- S2 13.93
- S3 13.37
Norris Medicines Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results | |
| 2025-08-14 | Quarterly Results | |
| 2025-05-28 | Audited Results | |
| 2025-02-13 | Quarterly Results & Others | Inter-alia, to consider 1. Requests from Mr. Nimish Bhishma Thakore, for reclassification from Promoter / Promoter Group into Public Category. 2. Other business matters. |
| 2024-11-14 | Quarterly Results |
Norris Medicines F&O
About Norris Medicines
- NSE Symbol
- NORRIS
- BSE Symbol
- 524414
- ISIN
- INE744C01029
Similar Stocks to Norris Medicines
Norris Medicines FAQs
Norris Medicines share price is ₹14 As on 06 February, 2026 | 11:51
The Market Cap of Norris Medicines is ₹14.5 Cr As on 06 February, 2026 | 11:51
The P/E ratio of Norris Medicines is -9.4 As on 06 February, 2026 | 11:51
The PB ratio of Norris Medicines is -0.9 As on 06 February, 2026 | 11:51
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.